查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1516927

基因學的全球市場的評估:各類產品·服務，各技術，各用途，各研究類型，各終端用戶，各地區，機會，預測，2017年～2031年

Genomics Market Assessment, By Products and Services, By Technology, By Application, By Study Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 231 Pages | 商品交期: 3-5個工作天內

價格

全球基因組學市場規模預計將從 2023 年的 352.8 億美元增長到 2031 年的 1201.2 億美元，在我預測的 2024 年至 2031 年期間增長 16.55%。市場擴張得益於藥物發現和研發力度的加強、農業部門的快速擴張、癌症等慢性病患者的增加、製藥和生物技術公司的成長、主要市場進入者以及研究機構之間不斷加強的合作。研究機構。

世界各地癌症病例的增加是支持市場擴張的主要全球基因組市場趨勢之一。美國國家癌症研究所估計，2022 年全球將通報 2,000 萬新癌症病例。這種增加使得開發能夠透過抑制癌細胞的基因表現特徵、抑制引發異常生長的?以及關閉分子信號傳導途徑來幫助對抗疾病的藥物的需求不斷增加。這增加了市場需求並為市場提供了利潤豐厚的成長機會。

人口成長促使農業部門的快速擴張正在推動全球基因組學市場的需求。印度品牌資產基金會 (IBEF) 估計，2023-2024 年印度將生產 1.485 億噸糧食（僅 Kharif）。基因組學有望幫助農民減少實驗失敗的機會並提高產量和品質。此外，透過將性狀與遺傳特徵和基因聯繫起來，可以產生具有理想品質的雜種，幫助科學家識別理想的性狀，並改善涉及生物和生物脅迫耐受性的分子途徑，透過新性狀的表徵和鑑定來協助作物改良。

生物資訊學技術和基因分型的進步正在促進基因組學在臨床治療中的應用，基因組學的進步也有助於提高我們對罕見遺傳疾病和病症及其治療的了解。基因組學的進步得到了各種敏感測序技術的發展的支持，這些技術支持發現各種非編碼RNA，包括環狀RNA。此外，各生技公司之間不斷加強的合作和夥伴關係正在推動基因組學的進步。

本報告提供全球基因學市場相關調查，提供市場概要，以及各類產品·服務，各技術，各用途，各研究類型，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 調查手法

第2章 計劃的範圍和定義

第3章 摘要整理

第4章 全球基因學市場預測，2017年～2031年

  • 市場規模與預測
  • 各類產品·服務
  • 各技術
  • 各用途
  • 各研究類型
  • 各終端用戶
  • 各地區
  • 各企業市場佔有率(%)、2023年

第5章 全球基因學市場預測，各地區，2017年～2031年

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第6章 市場製圖，2023年

第7章 宏觀環境和產業結構

  • 供給需求分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL分析
  • 波特的五力分析

第8章 市場動態

第9章 法規結構和革新

第10章 主要加入企業的形勢

第11章 價格分析

第12章 案例研究

第13章 主要加入企業預測

  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd
  • Eppendorf SE
  • Danaher Corporation
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • GE HealthCare Technologies Inc.
  • Oxford Nanopore Technologies plc
  • Eurofins Scientific SE

第14章 策略性建議

第15章 諮詢方式和免責聲明

Product Code: MX11611

Global genomics market is projected to witness a CAGR of 16.55% during the forecast period 2024-2031F, growing from USD 35.28 billion in 2023 to USD 120.12 billion in 2031F. The market's expansion is supported by the rising efforts towards drug discovery and development, rapid expansion of the agriculture sector, increasing cases of chronic diseases such as cancer, growth of pharmaceutical and biotechnology companies, and rising collaborations between key market players and research institutions.

The rising cases of cancer in various regions across the globe is one of the leading global genomics market trends that is supporting the expansion of the market. According to the estimates of the National Cancer Institute, 20 million new cases of cancer were reported in 2022 across the globe. This increase is propelling the requirement for cancer genomics as research in genomic changes that are caused because of cancer allows the development of drugs that aid in fighting the disease by blocking gene expression characteristics of cancer cells, inhibiting enzymes responsible for triggering abnormal growth, and halting molecular signaling pathways. Thus, boosting the market demand and providing lucrative growth opportunities to the market.

The rapid expansion of the agriculture sector due to increasing population growth is boosting the global genomics market demand. The India Brand Equity Foundation (IBEF) estimates that 148.5 million tons of foodgrains were produced in 2023-2024 (Kharif only) in India. Genomics is expected to aid agriculturists in reducing the chances of failure in experiments and enhancing the quantity and quality of the yield. It also allows for the production of hybrids that possess desirable qualities by linking traits to gene signatures or genes, aiding scientists in the identification of desirable traits and aiding in crop improvement by characterizing molecular pathways involved with abiotic and biotic stress tolerance and identification of novel traits and sources of variations as well as genetic variations.

Technological Advancements Boost Market Growth

Advancements in bioinformatic techniques and genotyping are aiding the translation of genomics in clinical care, and advancements in genomics are aiding in enhancing knowledge about rare genetic diseases and disorders and their treatments. Advancements in genomics have been supported by the development of various sensitive sequencing technologies that have supported the discovery of various noncoding RNAs, including circular RNA. Additionally, advancements in genomics are boosted by the rising collaborations and partnerships between various biotechnology companies. In March 2024, Eurofins Genomics Europe Genotyping A/S and MGI Tech announced a collaboration for elevating precision health with the help of DNBSEQ-T20X2 Sequencer and related technologies. The sequencer is designed to address the different sequencing scenarios that can be challenging, including single-cell sequencing, among others. With this collaboration, the companies aim to improve the accessibility of sequencing that is cost effective for researchers across the globe and bolster advancements in genomics research.

Government Initiatives Support Market Expansion

The increasing number of government-supported and funded genome projects is boosting the global genomics market size. Such projects aid in the identification of genetic mutations in different regional populations that increase their vulnerability to specific diseases and support the development of treatment solutions. For instance, the Genome India Project, funded by the Ministry of Science and Technology, Government of India, is a country-wide collaboration that involves 20 national institutes and aims to develop a reference genome for the Indian population that will support the designing of genetic chips that are disease-specific and genome-wide for low-cost research and diagnostics. In January 2024, whole genome sequencing of over 10,000 individuals was completed and the data was achieved at the Indian Biological Data Centre (IBDC). The database is expected to be instrumental in conducting next generation clinical research in the country and foster large scale human genetic studies, which are expected to improve drug development and public health interventions.

North America is Expected to Account Significant Market Share

The expansion of the market in the region is supported by the rising investments towards the biotechnology sector, growing preference for personalized medicines, increasing cases of cancer, rapid expansion of the pharmaceutical sector, and novel product launches by key market players based in the region. According to the estimates of the National Cancer Institute, 2,000,000 individuals are expected to be diagnosed with cancer in 2024 in the United States.

Furthermore, the prevalence of several other chronic diseases and disorders is also increasing in the region, which in turn is boosting the research efforts of different pharmaceutical companies and research organizations towards drug discovery and development. The profiling of metabolomics, genomics, proteomics, and transcriptomics, among others, plays a crucial role in drug discovery. With the help of genomic analysis technologies such as next-generation sequencing (NGS), biotechnology and pharmaceutical sectors gain enhanced knowledge about the various genetic variants that are associated with diseases. The resulting insights can strengthen the multi-analyte tumor analysis and augment the development of targeted therapies. Researchers are also focusing on research activities to boost the efficacy of treatment plans in patients by evaluating how human genome variations affect the response of patients to different medications.

Academic and Research Institutes Witness Significant Growth

The rising investments in research activities due to the growing awareness about the various applications of genomics in various fields are supporting the expansion of the segment. With the help of pharmacogenomics, researchers are able to study the impact of human genome variations in dictating the response of a patient to different medications. This, in turn, allows healthcare professionals to reduce negative drug reactions, decrease the occurrence of side effects, and boost the intended use of a treatment or medication.

Additionally, research and academic institutions across the globe are also deploying pharmacogenomics analysis to determine the impact of different medications on patients. Tongji University (Shanghai, China) is conducting an interventional study to understand the genomic analysis of antidepressants. With the help of the Asian Screening Array (ASA) chip detection technology (Illumina, Inc.) and PCR gene chip detection method, the researchers are able to obtain the genetic information of polymorphic sites. In the intervention group, the pharmacogenomic analysis of antidepressants was completed prior to their usage, and the appropriate antidepressants were selected on the basis of the characteristics of pharmacodynamics and pharmacokinetics of the patient. The study is expected to conclude in December 2026.

Future Market Scenario (2024-2031F)

As per the global genomics market analysis, the market is expected to witness significant growth in the coming years. The increasing investments by various countries towards genomic medicine research will support this growth. In February 2024, the Australian government announced an investment of USD 330 million (AUD 500 million) in genomic research. The investment is expected to reduce the requirement of unnecessary interventions as well as healthcare costs and improve diagnostics and testing of various diseases, aiding healthcare providers to improve patient outcomes by personalizing treatment outcomes. The Genomics Health Futures Mission funds aim to boost the clinical utilization of genomics and transform the lives of Australians by delivering advanced treatment, testing, and diagnostic solutions. Such investments are expected to provide lucrative growth opportunities for the market. Additionally, advancements and innovations, including long-read and short-read technologies, analysis of gene lengths in humans, and sequencing of DNA in real time, are also anticipated to support the market's growth as they aid in the procurement of results in a time-efficient manner.

Key Players Landscape and Outlook

Rising collaborations between key market players and research institutes, and other major healthcare companies are boosting the global genomics market growth. In March 2024, Thermo Fisher Scientific Inc. and Bayer AG announced a collaboration to support the development of next-generation companion diagnostic assays. The assays will aid in identifying the patients that are eligible for precision cancer therapies provided by Bayer, and the partnership aims to provide rapid turnaround time and decentralized genomic testing. Companion diagnostics allows healthcare professionals to match patients with therapies most suitable to their requirements and is important for facilitating different approaches for personalized treatment. Thus, aiding healthcare professionals in providing advanced care to their patients.

In June 2024, Illumina announced a collaboration with National Cancer Centre Singapore (NCCS) to advance genomics research for rare cancers and will focus on profiling young adult and adolescent (AYA) lymphoma patients. This process will leverage NovaSeq 6000 systems, Illumina's genome sequencing platforms, to study the genetic links between disease and health and provide better treatment and diagnosis. This effort is expected to provide valuable insights and enhance patient outcomes and care in the Asian population as the classification systems used historically have not been studied in them.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Genomics Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Products and Services
    • 4.2.1. Products
      • 4.2.1.1. Instruments/Systems/Software
      • 4.2.1.2. Consumables and Reagents
    • 4.2.2. Services
      • 4.2.2.1. Core Genomics Services
      • 4.2.2.2. Biomarker Translation Services
      • 4.2.2.3. NGS-based Services
      • 4.2.2.4. Computational Services
      • 4.2.2.5. Others
  • 4.3. By Technology
    • 4.3.1. PCR
    • 4.3.2. Sequencing
    • 4.3.3. Flow Cytometry
    • 4.3.4. Microarrays
    • 4.3.5. Nucleic Acid Extraction and Purification
    • 4.3.6. Others
  • 4.4. By Application
    • 4.4.1. Drug Discovery and Development
    • 4.4.2. Agriculture and Animal Research
    • 4.4.3. Diagnostics
    • 4.4.4. Precision Medicine
    • 4.4.5. Others
  • 4.5. By Study Type
    • 4.5.1. Biomarker Discovery
    • 4.5.2. Functional Genomics
    • 4.5.3. Epigenomics
    • 4.5.4. Pathway Analysis
    • 4.5.5. Others
  • 4.6. By End-user
    • 4.6.1. Hospitals and Clinics
    • 4.6.2. Pharmaceutical and Biotechnology Companies
    • 4.6.3. Academic and Research Institutes
    • 4.6.4. Others
  • 4.7. By Region
    • 4.7.1. North America
    • 4.7.2. South America
    • 4.7.3. Europe
    • 4.7.4. Asia-Pacific
    • 4.7.5. Middle East and Africa
  • 4.8. By Company Market Share (%), 2023

5. Global Genomics Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Products and Services
      • 5.1.2.1. Products
        • 5.1.2.1.1. Instruments/Systems/Software
        • 5.1.2.1.2. Consumables and Reagents
      • 5.1.2.2. Services
        • 5.1.2.2.1. Core Genomics Services
        • 5.1.2.2.2. Biomarker Translation Services
        • 5.1.2.2.3. NGS-based Services
        • 5.1.2.2.4. Computational Services
        • 5.1.2.2.5. Others
    • 5.1.3. By Technology
      • 5.1.3.1. PCR
      • 5.1.3.2. Sequencing
      • 5.1.3.3. Flow Cytometry
      • 5.1.3.4. Microarrays
      • 5.1.3.5. Nucleic Acid Extraction and Purification
      • 5.1.3.6. Others
    • 5.1.4. By Application
      • 5.1.4.1. Drug Discovery and Development
      • 5.1.4.2. Agriculture and Animal Research
      • 5.1.4.3. Diagnostics
      • 5.1.4.4. Precision Medicine
      • 5.1.4.5. Others
    • 5.1.5. By Study Type
      • 5.1.5.1. Biomarker Discovery
      • 5.1.5.2. Functional Genomics
      • 5.1.5.3. Epigenomics
      • 5.1.5.4. Pathway Analysis
      • 5.1.5.5. Others
    • 5.1.6. By End-user
      • 5.1.6.1. Hospitals and Clinics
      • 5.1.6.2. Pharmaceutical and Biotechnology Companies
      • 5.1.6.3. Academic and Research Institutes
      • 5.1.6.4. Others
    • 5.1.7. United States*
      • 5.1.7.1. Market Size & Forecast
        • 5.1.7.1.1. By Value
        • 5.1.7.1.2. By Volume
      • 5.1.7.2. By Products and Services
        • 5.1.7.2.1. Products
          • 5.1.7.2.1.1. Instruments/Systems/Software
          • 5.1.7.2.1.2. Consumables and Reagents
        • 5.1.7.2.2. Services
          • 5.1.7.2.2.1. Core Genomics Services
          • 5.1.7.2.2.2. Biomarker Translation Services
          • 5.1.7.2.2.3. NGS-based Services
          • 5.1.7.2.2.4. Computational Services
          • 5.1.7.2.2.5. Others
      • 5.1.7.3. By Technology
        • 5.1.7.3.1. PCR
        • 5.1.7.3.2. Sequencing
        • 5.1.7.3.3. Flow Cytometry
        • 5.1.7.3.4. Microarrays
        • 5.1.7.3.5. Nucleic Acid Extraction and Purification
        • 5.1.7.3.6. Others
      • 5.1.7.4. By Application
        • 5.1.7.4.1. Drug Discovery and Development
        • 5.1.7.4.2. Agriculture and Animal Research
        • 5.1.7.4.3. Diagnostics
        • 5.1.7.4.4. Precision Medicine
        • 5.1.7.4.5. Others
      • 5.1.7.5. By Study Type
        • 5.1.7.5.1. Biomarker Discovery
        • 5.1.7.5.2. Functional Genomics
        • 5.1.7.5.3. Epigenomics
        • 5.1.7.5.4. Pathway Analysis
        • 5.1.7.5.5. Others
      • 5.1.7.6. By End-user
        • 5.1.7.6.1. Hospitals and Clinics
        • 5.1.7.6.2. Pharmaceutical and Biotechnology Companies
        • 5.1.7.6.3. Academic and Research Institutes
        • 5.1.7.6.4. Others
    • 5.1.8. Canada
    • 5.1.9. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Products and Services
  • 6.2. By Technology
  • 6.3. By Application
  • 6.4. By Study Type
  • 6.5. By End-user
  • 6.6. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Illumina, Inc.
  • 13.3. F. Hoffmann-La Roche Ltd
  • 13.4. Eppendorf SE
  • 13.5. Danaher Corporation
  • 13.6. QIAGEN N.V.
  • 13.7. Bio-Rad Laboratories, Inc.
  • 13.8. GE HealthCare Technologies Inc.
  • 13.9. Oxford Nanopore Technologies plc
  • 13.10. Eurofins Scientific SE

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 4. Global Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global Genomics Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 7. Global Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 8. Global Genomics Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 11. North America Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 12. North America Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 13. North America Genomics Market Share (%), By Application, 2017-2031F
  • Figure 14. North America Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 15. North America Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 16. North America Genomics Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 19. United States Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 20. United States Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 21. United States Genomics Market Share (%), By Application, 2017-2031F
  • Figure 22. United States Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 23. United States Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 24. Canada Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 26. Canada Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 27. Canada Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 28. Canada Genomics Market Share (%), By Application, 2017-2031F
  • Figure 29. Canada Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 30. Canada Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 31. Mexico Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 33. Mexico Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 34. Mexico Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 35. Mexico Genomics Market Share (%), By Application, 2017-2031F
  • Figure 36. Mexico Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 37. Mexico Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 38. Europe Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 40. Europe Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 41. Europe Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 42. Europe Genomics Market Share (%), By Application, 2017-2031F
  • Figure 43. Europe Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 44. Europe Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 45. Europe Genomics Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. Germany Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 49. Germany Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 50. Germany Genomics Market Share (%), By Application, 2017-2031F
  • Figure 51. Germany Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 52. Germany Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 53. France Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 55. France Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 56. France Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 57. France Genomics Market Share (%), By Application, 2017-2031F
  • Figure 58. France Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 59. France Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 60. Italy Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 62. Italy Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 63. Italy Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 64. Italy Genomics Market Share (%), By Application, 2017-2031F
  • Figure 65. Italy Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 66. Italy Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 67. United Kingdom Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 69. United Kingdom Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 70. United Kingdom Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 71. United Kingdom Genomics Market Share (%), By Application, 2017-2031F
  • Figure 72. United Kingdom Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 73. United Kingdom Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 74. Russia Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 76. Russia Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 77. Russia Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 78. Russia Genomics Market Share (%), By Application, 2017-2031F
  • Figure 79. Russia Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 80. Russia Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 81. Netherlands Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Netherlands Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 83. Netherlands Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 84. Netherlands Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 85. Netherlands Genomics Market Share (%), By Application, 2017-2031F
  • Figure 86. Netherlands Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 87. Netherlands Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 88. Spain Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Spain Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Spain Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 91. Spain Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 92. Spain Genomics Market Share (%), By Application, 2017-2031F
  • Figure 93. Spain Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 94. Spain Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 95. Turkey Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Turkey Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 97. Turkey Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 98. Turkey Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 99. Turkey Genomics Market Share (%), By Application, 2017-2031F
  • Figure 100. Turkey Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 101. Turkey Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 102. Poland Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. Poland Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 104. Poland Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 105. Poland Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 106. Poland Genomics Market Share (%), By Application, 2017-2031F
  • Figure 107. Poland Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 108. Poland Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 109. South America Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. South America Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 111. South America Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 112. South America Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 113. South America Genomics Market Share (%), By Application, 2017-2031F
  • Figure 114. South America Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 115. South America Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 116. South America Genomics Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Brazil Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 119. Brazil Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 120. Brazil Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 121. Brazil Genomics Market Share (%), By Application, 2017-2031F
  • Figure 122. Brazil Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 123. Brazil Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 124. Argentina Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Argentina Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 126. Argentina Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 127. Argentina Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 128. Argentina Genomics Market Share (%), By Application, 2017-2031F
  • Figure 129. Argentina Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 130. Argentina Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 131. Asia-Pacific Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Asia-Pacific Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 133. Asia-Pacific Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 134. Asia-Pacific Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 135. Asia-Pacific Genomics Market Share (%), By Application, 2017-2031F
  • Figure 136. Asia-Pacific Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 137. Asia- Pacific Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 138. Asia-Pacific Genomics Market Share (%), By Country, 2017-2031F
  • Figure 139. India Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. India Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 141. India Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 142. India Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 143. India Genomics Market Share (%), By Application, 2017-2031F
  • Figure 144. India Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 145. India Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 146. China Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 147. China Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 148. China Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 149. China Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 150. China Genomics Market Share (%), By Application, 2017-2031F
  • Figure 151. China Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 152. China Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 153. Japan Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 154. Japan Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 155. Japan Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 156. Japan Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 157. Japan Genomics Market Share (%), By Application, 2017-2031F
  • Figure 158. Japan Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 159. Japan Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 160. Australia Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 161. Australia Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 162. Australia Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 163. Australia Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 164. Australia Genomics Market Share (%), By Application, 2017-2031F
  • Figure 165. Australia Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 166. Australia Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 167. Vietnam Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Vietnam Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 169. Vietnam Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 170. Vietnam Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 171. Vietnam Genomics Market Share (%), By Application, 2017-2031F
  • Figure 172. Vietnam Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 173. Vietnam Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 174. South Korea Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 175. South Korea Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 176. South Korea Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 177. South Korea Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 178. South Korea Genomics Market Share (%), By Application, 2017-2031F
  • Figure 179. South Korea Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 180. South Korea Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 181. Indonesia Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. Indonesia Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. Indonesia Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 184. Indonesia Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 185. Indonesia Genomics Market Share (%), By Application, 2017-2031F
  • Figure 186. Indonesia Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 187. Indonesia Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 188. Philippines Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 189. Philippines Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 190. Philippines Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 191. Philippines Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 192. Philippines Genomics Market Share (%), By Application, 2017-2031F
  • Figure 193. Philippines Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 194. Philippines Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 195. Middle East & Africa Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Middle East & Africa Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 197. Middle East & Africa Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 198. Middle East & Africa Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 199. Middle East & Africa Genomics Market Share (%), By Application, 2017-2031F
  • Figure 200. Middle East & Africa Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 201. Middle East & Africa Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 202. Middle East & Africa Genomics Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 204. Saudi Arabia Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 205. Saudi Arabia Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 206. Saudi Arabia Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 207. Saudi Arabia Genomics Market Share (%), By Application, 2017-2031F
  • Figure 208. Saudi Arabia Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 209. Saudi Arabia Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 210. UAE Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 211. UAE Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 212. UAE Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 213. UAE Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 214. UAE Genomics Market Share (%), By Application, 2017-2031F
  • Figure 215. UAE Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 216. UAE Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 217. South Africa Genomics Market, By Value, In USD Billion, 2017-2031F
  • Figure 218. South Africa Genomics Market, By Volume, In Million Units, 2017-2031F
  • Figure 219. South Africa Genomics Market Share (%), By Products and Services, 2017-2031F
  • Figure 220. South Africa Genomics Market Share (%), By Technology, 2017-2031F
  • Figure 221. South Africa Genomics Market Share (%), By Application, 2017-2031F
  • Figure 222. South Africa Genomics Market Share (%), By Study Type, 2017-2031F
  • Figure 223. South Africa Genomics Market Share (%), By End-user, 2017-2031F
  • Figure 224. By Products and Services Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Study Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023